I am powered to bring you the Sinner Extracorporeal Shockwave system, designed for clinics that want reliable therapy with great value. Our equipment combines precise energy control, ergonomic design, and durable components to deliver consistent results in musculoskeletal treatments. For B2B buyers, I know price matters—that’s why we offer Cheap pricing tiers without compromising performance, plus a Service-first approach that includes training, remote monitoring, and rapid on-site support. With intuitive setup and short learning curves, your team can start treating patients sooner, increasing throughput and patient satisfaction. The device includes safety features, adjustability, and robust after-sales service, so you can rely on it for years. We also provide scalable service packages, maintenance plans, and certified technicians who align with your clinic’s workflow. If you’re upgrading or expanding, choose a cost-efficient asset that doubles as an upgrade to your service quality.
Global procurement leaders seek medical equipment that combines clinical excellence with dependable service. An End-to-End Solution for extracorporeal shockwave therapy delivers consistent outcomes via robust hardware, precise energy delivery, and intuitive interfaces, backed by diagnostics. With a single contact for devices, consumables, training, and after‑sales support, clinics lower lifecycle costs and stay compliant across regions. Scalable configurations, installation, remote monitoring, and rapid spare‑parts access keep busy centers running smoothly. Global buyers benefit from a unified supply chain that ties planning to warranty, SLAs, and post‑market support. Standardized quality and traceability simplify audits across markets. Consolidating procurement under one end‑to‑end solution offers reliability, predictable lead times, and a partner who adapts to local requirements and evolving ESWT practices. The result is cost efficiency, lower risk, and faster patient access to proven therapies.
| Parameter | Description | Typical Range | Unit | Measurement Context | Notes |
|---|---|---|---|---|---|
| Energy Flux Density (EFD) | Energy delivered per pulse per unit area | 0.08–0.28 | mJ/mm2 | Focused ESWT settings in clinical protocols | Commonly reported; varies by device |
| Shocks per Session | Number of acoustic impulses delivered during a treatment | 2000–4000 | shocks | Standard protocol for tendinopathy and insertional pain | Device- and condition-dependent |
| Sessions per Course | Number of treatment sessions in a course | 1–6 | sessions | Short to medium course | Most protocols use 3 sessions |
| Session Duration | Time per session | 5–10 | minutes | In-clinic procedure | Longer durations yield higher cumulative dose |
| Pain Reduction (NRS) | Change in pain score on Numeric Rating Scale (0–10) | 2–5 | points | Measured at 6–12 weeks post-treatment | Clinically meaningful improvement |
| Functional Improvement | Relative improvement in function (patient-reported) | 15–60 | percent | Disease-specific score (e.g., ME/FA scores) | Clinically meaningful difference |
| Return to Activity Time | Time to resume normal activity | 2–12 | weeks | Depends on baseline function | Shorter with optimized dosing |
| Adverse Events Rate | Incidence of reported side effects | 0–5 | percent | Post-treatment period | Mostly mild, transient effects |
| Patient Satisfaction | Self-reported satisfaction after course | 70–95 | percent | Across musculoskeletal indications | Generally high satisfaction in reviews |